Skip to main content
Erschienen in: Supportive Care in Cancer 4/2019

23.01.2019 | Original Article

Inclusion of children in the initial conversation about their cancer diagnosis: impact on parent experiences of the communication process

verfasst von: Sarah R. Brand McCarthy, Tammy I. Kang, Jennifer W. Mack

Erschienen in: Supportive Care in Cancer | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Including children in medical conversations is considered the standard of care for children with cancer. However, previous qualitative research has raised concerns about how the child’s presence impacts the parent’s communication experience. The current study examines the frequency and impact of child presence during a serious medical conversation on the parent’s communication experience in pediatric oncology.

Methods

Three hundred sixty parents of children newly diagnosed with cancer completed questionnaires assessing the child’s presence during the initial conversation with the oncologist about diagnosis and treatment and parental communication experiences. Primary oncologists completed a survey question about the child’s prognosis.

Results

Sixty-one percent of children were present during the initial conversation, with lowest rates among children aged 3–6 (44%) and 7–12 (44%). Child presence was not associated with parents’ reports that they received prognostic information (p = 0.20), high-quality information (p = 0.19), or high-quality communication about the child’s cancer (p = 1.0).

Discussion

The parent’s communication experience is not diminished by the choice to include the child. Given the bioethical imperative to include children in conversations about serious illness whenever possible, this concern should not be used to exclude children, but rather to give parents additional time of their own when needed to fully process decisions.
Literatur
1.
Zurück zum Zitat Spinetta JJ, Jankovic M, Masera G, Ablin AR, Barr RD, Arush MWB, D’Angio GJ, van Dongen-Melman J, Eden T, Epelman C, Martins AG, Greenberg ML, Kosmidis HV, Oppenheim D, Zeltzer PM (2009) Optimal care for the child with cancer: a summary statement from the SIOP Working Committee on Psychosocial Issues in Pediatric Oncology. Pediatr Blood Cancer 52(7):904–907CrossRefPubMed Spinetta JJ, Jankovic M, Masera G, Ablin AR, Barr RD, Arush MWB, D’Angio GJ, van Dongen-Melman J, Eden T, Epelman C, Martins AG, Greenberg ML, Kosmidis HV, Oppenheim D, Zeltzer PM (2009) Optimal care for the child with cancer: a summary statement from the SIOP Working Committee on Psychosocial Issues in Pediatric Oncology. Pediatr Blood Cancer 52(7):904–907CrossRefPubMed
2.
Zurück zum Zitat McCabe MA (1996) Involving children and adolescents in medical decision making: developmental and clinical considerations. J Pediatr Psychol 21(4):505–516CrossRefPubMed McCabe MA (1996) Involving children and adolescents in medical decision making: developmental and clinical considerations. J Pediatr Psychol 21(4):505–516CrossRefPubMed
3.
Zurück zum Zitat Ranmal R, Prictor M, Scott J (2008) Interventions for improving communication with children and adolescents about their cancer. Cochrane Database Syst Rev 8(4):CD002969 Ranmal R, Prictor M, Scott J (2008) Interventions for improving communication with children and adolescents about their cancer. Cochrane Database Syst Rev 8(4):CD002969
4.
Zurück zum Zitat Coyne I (2006) Consultation with children in hospital: children, parents’ and nurses’ perspectives. J Clin Nurs 15(1):61–71CrossRefPubMed Coyne I (2006) Consultation with children in hospital: children, parents’ and nurses’ perspectives. J Clin Nurs 15(1):61–71CrossRefPubMed
5.
Zurück zum Zitat Spinetta JJ, Masera G, Eden T et al (2002) Refusal, non-compliance, and abandonment of treatment in children and adolescents with cancer. A report of the SIOP Working Committee on Phychosocial Issues in Pediatric Oncology. Pediatr Blood Cancer 38(2):114–117 Spinetta JJ, Masera G, Eden T et al (2002) Refusal, non-compliance, and abandonment of treatment in children and adolescents with cancer. A report of the SIOP Working Committee on Phychosocial Issues in Pediatric Oncology. Pediatr Blood Cancer 38(2):114–117
6.
Zurück zum Zitat Keim MC, Lehmann V, Shultz EL, Winning AM, Rausch JR, Barrera M, Jo Gilmer M, Murphy LK, Vannatta KA, Compas BE, Gerhardt CA (2017) Parent-child communication and adjustment among children with advanced and non-advanced cancer in the first year following diagnosis or relapse. J Pediatr Psychol 42:871–881CrossRefPubMedPubMedCentral Keim MC, Lehmann V, Shultz EL, Winning AM, Rausch JR, Barrera M, Jo Gilmer M, Murphy LK, Vannatta KA, Compas BE, Gerhardt CA (2017) Parent-child communication and adjustment among children with advanced and non-advanced cancer in the first year following diagnosis or relapse. J Pediatr Psychol 42:871–881CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Levetown M (2008) Communicating with children and families: from everyday interactions to skill in conveying distressing information. Pediatrics 121(5):e1441–e1460CrossRefPubMed Levetown M (2008) Communicating with children and families: from everyday interactions to skill in conveying distressing information. Pediatrics 121(5):e1441–e1460CrossRefPubMed
9.
Zurück zum Zitat Young B, Dixon-Woods M, Windridge KC, Heney D (2003) Managing communication with young people who have a potentially life threatening chronic illness: qualitative study of patients and parents. BMJ 326(7384):305CrossRefPubMedPubMedCentral Young B, Dixon-Woods M, Windridge KC, Heney D (2003) Managing communication with young people who have a potentially life threatening chronic illness: qualitative study of patients and parents. BMJ 326(7384):305CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Young B, Ward J, Salmon P, Gravenhorst K, Hill J, Eden T (2011) Parents’ experiences of their children’s presence in discussions with physicians about leukemia. Pediatrics 127(5):e1230–e1238CrossRefPubMed Young B, Ward J, Salmon P, Gravenhorst K, Hill J, Eden T (2011) Parents’ experiences of their children’s presence in discussions with physicians about leukemia. Pediatrics 127(5):e1230–e1238CrossRefPubMed
11.
Zurück zum Zitat Mack JW, Wolfe J, Grier HE, Cleary PD, Weeks JC (2006) Communication about prognosis between parents and physicians of children with cancer: parent preferences and the impact of prognostic information. J Clin Oncol 24(33):5265–5270CrossRefPubMed Mack JW, Wolfe J, Grier HE, Cleary PD, Weeks JC (2006) Communication about prognosis between parents and physicians of children with cancer: parent preferences and the impact of prognostic information. J Clin Oncol 24(33):5265–5270CrossRefPubMed
12.
Zurück zum Zitat Mack JW, Cook EF, Wolfe J, Grier HE, Cleary PD, Weeks JC (2007) Understanding of prognosis among parents of children with cancer: parental optimism and the parent-physician interaction. J Clin Oncol 25(11):1357–1362CrossRefPubMed Mack JW, Cook EF, Wolfe J, Grier HE, Cleary PD, Weeks JC (2007) Understanding of prognosis among parents of children with cancer: parental optimism and the parent-physician interaction. J Clin Oncol 25(11):1357–1362CrossRefPubMed
13.
Zurück zum Zitat Mack JW, Wolfe J, Cook EF, Grier HE, Cleary PD, Weeks JC (2009) Peace of mind and sense of purpose as core existential issues among parents of children with cancer. Arch Pediat Adol Med 163(6):519–524CrossRef Mack JW, Wolfe J, Cook EF, Grier HE, Cleary PD, Weeks JC (2009) Peace of mind and sense of purpose as core existential issues among parents of children with cancer. Arch Pediat Adol Med 163(6):519–524CrossRef
14.
Zurück zum Zitat Mack JW, Wolfe J, Cook EF, Grier HE, Cleary PD, Weeks JC (2007) Hope and prognostic disclosure. J Clin Oncol 25(35):5636–5642CrossRefPubMed Mack JW, Wolfe J, Cook EF, Grier HE, Cleary PD, Weeks JC (2007) Hope and prognostic disclosure. J Clin Oncol 25(35):5636–5642CrossRefPubMed
15.
Zurück zum Zitat Kaye E, Mack JW (2013) Parent perceptions of the quality of information received about a child’s cancer. Pediatr Blood Cancer 60(11):1896–1901CrossRefPubMed Kaye E, Mack JW (2013) Parent perceptions of the quality of information received about a child’s cancer. Pediatr Blood Cancer 60(11):1896–1901CrossRefPubMed
16.
Zurück zum Zitat Cleary PD, Edgman-Levitan S, Roberts M, Moloney TW, McMullen W, Walker JD, Delbanco TL (1991) Patients evaluate their hospital care: a national survey. Health Aff 10(4):254–267CrossRef Cleary PD, Edgman-Levitan S, Roberts M, Moloney TW, McMullen W, Walker JD, Delbanco TL (1991) Patients evaluate their hospital care: a national survey. Health Aff 10(4):254–267CrossRef
17.
Zurück zum Zitat Hays RD, Shaul JA, Williams VS et al (1999) Psychometric properties of the CAHPS™ 1.0 survey measures. Med Care 37(3):MS22–MS31PubMed Hays RD, Shaul JA, Williams VS et al (1999) Psychometric properties of the CAHPS™ 1.0 survey measures. Med Care 37(3):MS22–MS31PubMed
18.
Zurück zum Zitat Katz AL, Webb SA, AAP Committee on Bioethics (2016) Informed consent in decision-making in pediatric practice. Pediatrics 138:e20161486CrossRef Katz AL, Webb SA, AAP Committee on Bioethics (2016) Informed consent in decision-making in pediatric practice. Pediatrics 138:e20161486CrossRef
19.
Zurück zum Zitat Masera G, Chesler MA, Jankovic M et al (1997) SIOP Working Committee on psychosocial issues in pediatric oncology: guidelines for communication of the diagnosis. Pediatr Blood Cancer 28(5):382–385 Masera G, Chesler MA, Jankovic M et al (1997) SIOP Working Committee on psychosocial issues in pediatric oncology: guidelines for communication of the diagnosis. Pediatr Blood Cancer 28(5):382–385
20.
Zurück zum Zitat Bluebond-Langner M, Belasco JB, Wander MD (2010) “I want to live, until I don’t want to live anymore”: involving children with life-threatening and life-shortening illnesses in decision making about care and treatment. Nurs Clin N Am 45(3):329–343CrossRef Bluebond-Langner M, Belasco JB, Wander MD (2010) “I want to live, until I don’t want to live anymore”: involving children with life-threatening and life-shortening illnesses in decision making about care and treatment. Nurs Clin N Am 45(3):329–343CrossRef
21.
Zurück zum Zitat Angiolillo AL, Simon C, Kodish E, Lange B, Noll RB, Ruccione K, Matloub Y (2004) Staged informed consent for randomized clinical trial in childhood leukemia: impact on the consent process. Pediatr Blood Cancer 42(5):433–437CrossRefPubMed Angiolillo AL, Simon C, Kodish E, Lange B, Noll RB, Ruccione K, Matloub Y (2004) Staged informed consent for randomized clinical trial in childhood leukemia: impact on the consent process. Pediatr Blood Cancer 42(5):433–437CrossRefPubMed
22.
Zurück zum Zitat Johnson LM, Leek AC, Drotar D, Noll RB, Rheingold SR, Kodish ED, Baker JN (2015) Practical communication guidance to improve phase 1 informed consent conversations and decision-making in pediatric oncology. Cancer 121(14):2439–2448CrossRefPubMedPubMedCentral Johnson LM, Leek AC, Drotar D, Noll RB, Rheingold SR, Kodish ED, Baker JN (2015) Practical communication guidance to improve phase 1 informed consent conversations and decision-making in pediatric oncology. Cancer 121(14):2439–2448CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Brand SR, Fasciano K, Mack JW (2017) Communication preferences of pediatric cancer patients: talking about prognosis and their future life. Support Care Cancer 25(3):769–774CrossRefPubMed Brand SR, Fasciano K, Mack JW (2017) Communication preferences of pediatric cancer patients: talking about prognosis and their future life. Support Care Cancer 25(3):769–774CrossRefPubMed
24.
Zurück zum Zitat Clarke JN, Fletcher P (2003) Communication issues faced by parents who have a child diagnosed with cancer. J Pediatr Oncol Nurs 20(4):175–191CrossRefPubMed Clarke JN, Fletcher P (2003) Communication issues faced by parents who have a child diagnosed with cancer. J Pediatr Oncol Nurs 20(4):175–191CrossRefPubMed
Metadaten
Titel
Inclusion of children in the initial conversation about their cancer diagnosis: impact on parent experiences of the communication process
verfasst von
Sarah R. Brand McCarthy
Tammy I. Kang
Jennifer W. Mack
Publikationsdatum
23.01.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 4/2019
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-019-4653-3

Weitere Artikel der Ausgabe 4/2019

Supportive Care in Cancer 4/2019 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.